Study first to link weed killer Roundup® to convulsions in animals

A recent report by the United States Centers for Disease Control and Prevention found more than 80 percent of urine samples from children and adults in the U.S. contained the herbicide glyphosate. A study by Florida Atlantic University and Nova Southeastern University takes this research one step further and is the first to link the use of the herbicide Roundup®, a widely used weed killer, to convulsions in animals.

Glyphosate, the weed killer component in Roundup®, is the world’s most commonly used herbicide by volume and by land-area treated. Glyphosate-resistant crops account for almost 80 percent of transgenic crop cultivated land, which has resulted in an estimated 6.1 billion kilos of glyphosate sprayed across the world from 2005 to 2014. Roundup® is used at both industrial and consumer levels, and its use is projected to dramatically increase over the coming years. A major question, yet to be fully understood, is the potential impact of glyphosate on the nervous system.

"It is concerning how little we understand the impact of glyphosate on the nervous system," said Akshay S. Naraine, MSc., project lead and a Ph.D. student at FAU and the International Max Planck Research School for Synapses and Circuits. "More evidence is mounting for how prevalent exposure to glyphosate is, so this work hopefully pushes other researchers to expand on these findings and solidify where our concerns should be."

Results, published in Scientific Reports, showed that glyphosate and Roundup® increased seizure-like behavior in soil-dwelling roundworms and provides significant evidence that glyphosate targets GABA-A receptors. These communication points are essential for locomotion and are heavily involved in regulating sleep and mood in humans. What truly sets this research apart is that it was done at significantly less levels than recommended by the EPA and those used in past studies.

"The concentration listed for best results on the Roundup® Super Concentrate label is 0.98 percent glyphosate, which is about 5 tablespoons of Roundup® in 1 gallon of water," said Naraine. "A significant finding from our study reveals that just 0.002 percent glyphosate, a difference of about 300 times less herbicide than the lowest concentration recommended for consumer use, had concerning effects on the nervous system."

Using C. elegans, a soil-dwelling roundworm, researchers first tested glyphosate alone and then both the U.S. and United Kingdom formulations of Roundup® from two distinct time periods - before and after the U.K.'s 2016 ban on polyethoxylated tallowamine (POEAs). These conditions were selected to pinpoint which effects are specific to the active ingredient glyphosate, Roundup® formulations in general, the POEAs surfactants, or any combination of these.

The study found that the active ingredient glyphosate exacerbated convulsions in C. elegans and suggest the GABA-A receptor as a neurological target for the observed physiological changes. The data also indicate that there is an important distinction between exposure to glyphosate and Roundup®, with Roundup® exposure increasing the percentage of C. elegans that did not recover from seizure activity. The non-recovery phenotype and prolonged convulsions in C. elegans from this study have helped to set a foundation for understanding nuanced physiological effects of herbicide that occur at concentrations exponentially below neurotoxic levels.

"Given how widespread the use of these products is, we must learn as much as we can about the potential negative impacts that may exist," said Ken Dawson-Scully, Ph.D., lab head, professor, senior vice president and associate provost, Division of Research and Economic Development, Nova Southeastern University. "There have been studies done in the past that showed the potential dangers, and our study takes that one step further with some pretty dramatic results."

Findings also generate concern over how herbicide use might affect soil-dwelling organisms like C. elegans.

"These roundworms undergo convulsions under thermal stress, and our data strongly implicates glyphosate and Roundup® exposure in exacerbating convulsive effects. This could prove vital as we experience the effects of climate change," said Naraine.

This study provides evidence to further investigate how chronic exposure and accumulation may lead to neurodegenerative diseases such as Parkinson's disease. Importantly, there also is a sub-neurodegenerative threshold that may dramatically impact dysregulation of neurotransmission.

"As of now, there is no information for how exposure to glyphosate and Roundup® may affect humans diagnosed with epilepsy or other seizure disorders," said Dawson-Scully. "Our study indicates that there is significant disruption in locomotion and should prompt further vertebrate studies."

Study co-authors are Venkatesh Shanbhag, Ph.D., lead chemist and professor of chemistry, Halmos College of Arts and Sciences, NSU; Rebecca Aker who was a master's student at FAU while contributing to this research; and Isis Sweeney, Meghan Kalvey and Alexis Surtel, undergraduate students who contributed at FAU.

Naraine AS, Aker R, Sweeney I, Kalvey M, Surtel A, Shanbhag V, Dawson-Scully K.
Roundup and glyphosate's impact on GABA to elicit extended proconvulsant behavior in Caenorhabditis elegans.
Sci Rep. 2022 Aug 23;12(1):13655. doi: 10.1038/s41598-022-17537-w

Most Popular Now

Xenpozyme™ (olipudase alfa-rpcp) approved by FDA a…

The U.S. Food and Drug Administration (FDA) has approved Xenpozyme™ (olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid...

FDA grants Breakthrough Therapy Designation to Pfi…

Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designat...

Malaria booster vaccine shows durable high efficac…

Researchers from the University of Oxford and their partners have today reported new findings from their Phase 2b trial following the administration of a booster dose of ...

Research reveals widespread use of ineffective COV…

Monoclonal antibodies are laboratory-designed treatments tailor-made to fight specific infections. In early 2021, the U.S. Food & Drug Administration issued emergency use...

Strict COVID lockdowns in France improved cardiova…

A new paper in European Heart Journal - Digital Health, published by Oxford University Press, indicates that social-distancing measures like total lockdown have a measura...

Efficacy, cash and more will increase booster shot…

The more effective the COVID-19 booster, the more likely people are to get it, according to new Cornell research. And they are more likely to accept the booster shot with...

U.S. clinical trial evaluating antiviral for monke…

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. St...

Novartis invests in early technical development ca…

Novartis today announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will b...

Stem cell-gene therapy shows promise in ALS safety…

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier. This...

Drug turns cancer gene into "eat me" fla…

Tumor cells are notoriously good at evading the human immune system; they put up physical walls, wear disguises and handcuff the immune system with molecular tricks. Now...

Mucosal antibodies in the airways protect against …

High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three ...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a 30-µg booster dose of their Omicron BA.4/BA.5 bivalent-adapted COVID-19 vaccine (COMIRNATY® Original/Om...